Waters to Supply GeneProt s NJ Facility with $10 Million in Mass Spec Instruments and Services | GenomeWeb

NEW YORK, Dec. 3 — Gene Prot and Waters announced Monday an agreement to equip GeneProt’s new industrial-scale proteomics facility.

Waters, through its subsidiary Micromass UK, will buy a maximum of $10 million of equity securities in GeneProt. The proteomics company will in turn purchase from Micromass about $20 million in mass spectrometry machines and services. The two companies will also collaborate on product development for these instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.